The FDA has approved Merilog (insulin aspart-szjj), the FIRST rapid-acting insulin biosimilar to Novolog, for glycemic control in adults and children with diabetes. 🙌 This is a game-changer for millions living with diabetes in the U.S. 🌟
🩺 Why It Matters:
- Affordable alternative: Biosimilars foster competition and may lower insulin costs.
- Safety & Effectiveness: Merilog is clinically proven to match Novolog in managing blood sugar spikes.
🖋️ Available Forms:
- 3 mL prefilled pen
- 10 mL multiple-dose vial
💉 Quick Facts:
- Take 5-10 minutes before meals.
- Administer via subcutaneous injection (stomach, thighs, arms, or buttocks).